JCJonathan Carruthers

Jonathan Carruthers

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jonathan Carruthers has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The urban mycobiome of transport environments: Characterising the fungal composition of passive dust samples collected in railway stations in England

    by Emma Marczylo, Sameirah Macchiarulo, James Isaac, Jodi Brookes, Jonathan Carruthers, Thomas Finnie, Krusha V. Patel, Brian Crook, Philippa Douglas


  • Open Access

    Introducing a framework for within-host dynamics and mutations modelling of H5N1 influenza infection in humans

    by Daniel Higgins, Joshua Looker, Robert Sunnucks, Jonathan Carruthers, Thomas Finnie, Matt J. Keeling, Edward M. Hill

    Avian influenza A(H5N1) poses a public health risk due to its pandemic potential should the virus mutate to become human-to-human transmissible. To date, reported influenza A(H5N1) human cases have typically occurred in the lower respiratory tract with a high case fatality rate. There is prior evidence of some influenza A(H5N1) strains being a small number of amino acid mutations away from achieving droplet transmissibility, possibly allowing them to be spread between humans. We present a mechanistic within-host influenza A(H5N1) infection model, novel for its explicit consideration of the biological differences between the upper and lower respiratory tracts. We then estimate a distribution of viral lifespans and effective replication rates in human H5N1 influenza cases. By combining our within-host model with a viral mutation model, we determine the probability of an infected individual generating a droplet transmissible strain of influenza A(H5N1) through mutation. For three mutations, we found a peak probability of approximately 10 − 3 that a human case of H5N1 influenza produces at least one virion during the infectious period. Our findings provide insights into the risk of differing infectious pathways of influenza A(H5N1) (namely avian–human versus avian–mammal–human routes), demonstrating the three-mutation pathway being a cause of concern in human cases.


  • Open Access

    Using mixture density networks to emulate a stochastic within-host model of Francisella tularensis infection

    by Jonathan Carruthers, Thomas Finnie

    For stochastic models with large numbers of states, analytical techniques are often impractical, and simulations time-consuming and computationally demanding. This limitation can hinder the practical implementation of such models. In this study, we demonstrate how neural networks can be used to develop emulators for two outputs of a stochastic within-host model of Francisella tularensis infection: the dose-dependent probability of illness and the incubation period. Once the emulators are constructed, we employ Markov Chain Monte Carlo sampling methods to parameterize the within-host model using records of human infection. This inference is only possible through the use of a mixture density network to emulate the incubation period, providing accurate approximations of the corresponding probability distribution. Notably, these estimates improve upon previous approaches that relied on bacterial counts from the lungs of macaques. Our findings reveal a 50% infectious dose of approximately 10 colony-forming units and we estimate that the incubation period can last for up to 11 days following low dose exposure.

  • Open Access

    Using mixture density networks to emulate a stochastic within-host model of Francisella tularensis infection

    by Jonathan Carruthers, Thomas Finnie

    For stochastic models with large numbers of states, analytical techniques are often impractical, and simulations time-consuming and computationally demanding. This limitation can hinder the practical implementation of such models. In this study, we demonstrate how neural networks can be used to develop emulators for two outputs of a stochastic within-host model of Francisella tularensis infection: the dose-dependent probability of illness and the incubation period. Once the emulators are constructed, we employ Markov Chain Monte Carlo sampling methods to parameterize the within-host model using records of human infection. This inference is only possible through the use of a mixture density network to emulate the incubation period, providing accurate approximations of the corresponding probability distribution. Notably, these estimates improve upon previous approaches that relied on bacteria counts from the lungs of macaques. Our findings reveal a 50% infectious dose of approximately 10 colony-forming units and we estimate that the incubation period can last for up to 11 days following low dose exposure. Author summary: Francisella tularensis is a highly infectious bacterium that remains in the top category of biothreat agents. Release of aerosolized bacteria could lead to many cases of acute and severe pneumonia over the days following. Mathematical modelling can contribute to the response to such an outbreak, combining dispersion models and disease models to identify the source of release and predict where cases are most likely to occur. However, these models can be computationally demanding and time consuming to run. In this article, we use neural networks to emulate the likelihood of disease and the duration of the incubation period from a stochastic within-host model. This enables rapid predictions to be made across a wide range of doses, thereby improving the practical applications of the model.

  • Open Access

    Quantification of Ebola virus replication kinetics in vitro

    by Laura E. Liao, Jonathan Carruthers, Sophie J. Smither, Cl4 Virology Team, Simon A. Weller, Diane Williamson, Thomas R. Laws, Isabel García-Dorival, Julian Hiscox, Benjamin P. Holder, et al.

    Mathematical modelling has successfully been used to provide quantitative descriptions of many viral infections, but for the Ebola virus, which requires biosafety level 4 facilities for experimentation, modelling can play a crucial role. Ebola virus modelling efforts have primarily focused onin vivovirus kinetics, e.g., in animal models, to aid the development of antivirals and vaccines. But, thus far, these studies have not yielded a detailed specification of the infection cycle, which could provide a foundational description of the virus kinetics and thus a deeper understanding of their clinical manifestation. Here, we obtain a diverse experimental data set of the Ebola virus infectionin vitro, and then make use of Bayesian inference methods to fully identify parameters in a mathematical model of the infection. Our results provide insights into the distribution of time an infected cell spends in the eclipse phase (the period between infection and the start of virus production), as well as the rate at which infectious virions lose infectivity. We suggest how these results can be used in future models to describe co-infection with defective interfering particles, which are an emerging alternative therapeutic.